Alliance Honored by National Colorectal Cancer Roundtable
The National Colorectal Cancer Roundtable (NCCRT), founded by the American Cancer Society (ACS) and the Centers for Disease Control and Prevention (CDC), honored leaders with the 2022 80% In Every Community National Achievement Award, given in recognition of distinguished, ongoing efforts to increase colorectal cancer screening rates across the United States.
Among other awardees, the Colorectal Cancer Alliance received honors and $1,000 for its efforts in colorectal cancer prevention in 2021. Trudy Loper, the Alliance’s Senior Director Screening, discusses our work in this video:
A description of our work was as follows:
$1,000 Honoree: Colorectal Cancer Alliance
Category: Nonprofit Organization
Access to Screening: A Colorectal Cancer Alliance Prevention Initiative, Washington, DC
The Colorectal Cancer Alliance exists to end colorectal cancer (CRC) in our lifetime, a mission that guides our programmatic pillars to screen, care, and cure. Early indications showed COVID-19 having a devastating effect on colorectal cancer screening. We have invested resources to increase awareness, deliver screening recommendations, and support patients through the screening process. In January 2021, the Alliance set a goal to deliver 20,000 clinically valid, personalized colorectal cancer screening recommendations within two years. The Alliance prioritizes unscreened and at-risk individuals, with a focus on populations that experience the highest colorectal cancer disparities, and we help patients understand screening options and improve access to screening through digital navigation (quiz.getscreened.org) and personal contact with our team of certified patient and family support navigators. In the first year, the Alliance achieved 12.4 million media impressions, delivered 9,174 personalized screening recommendations, supported more than 4,000 people on their screening journey with live navigation, and facilitated more than 1,300 colorectal cancer screenings.
To view the NCCRT’s full press release and learn about the other organizations honored, please click here.
Top resources
FDA approves ColoSense, mt-sRNA screening test from Geneoscopy
ColoSense is a screening test for adults, 45 years of age or older, who are at average risk for developing colorectal cancer (CRC).
Legislation introduced to address young-onset CRC
Explore the urgent need for the Colorectal Cancer Early Detection Act (HR 7714), legislation aimed at combating the rising incidence of colorectal cancer among younger adults through enhanced screening, education, and research.
EPIC Act to Advance New CRC Therapies Needs Support
The EPIC Act would encourage investment in clinical trials for additional uses of existing drugs.